Search Results for FX

Product: Chromogenix Coamatic® Antithrombin

Product: Chromogenix Coatest® Heparin

Product: Chromogenix Factor Xa

Product: Chromogenix S-2302™

Product: Chromogenix S-2366™

Product: Chromogenix S-2765™

Product: DiaPharma CS FXa

Product: DiaPharma Factor X

Product: Diapharma Factor Xa Purified Cofactor, Human

Product: Pathway Diagnostics Human Prekallikrein Pool

Product: Pathway Diagnostics Prekallikrein Activator (PKA) Assay Standard

Product: Pathway Diagnostics Prekallikrein Activator Assay Ig Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Ig Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Kit

Product: Rossix FXIa Calibrator

Product: Rossix FXIa Control

Product: Rossix Phospholipid-TGT, 0.50mmol/L

Product: Rox Factor IX

Product: Rox Factor IX-A

Product: Rox Factor XIa

Product: ROX FXa Substrate

Product: Technochrom® anti-Xa

Product: Technochrom® FXIII Kit

Product: Technoclone Factor X Deficient Plasma

Product: Technoclone Factor X Deficient Plasma

Product: Technoclone Factor XIII Deficient Plasma

Product: Technoclone Fitzgerald Trait Plasma

Product: Technofluor® FXIII Activity

Page: Activated partial thromboplastin time (aPTT)

Page: Activated Protein C (APC) and Factor V Leiden

Page: CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY

Page: Chromogenic Substrates

Page: Clot Club

Page: Clot Club - Here The Clot Thickens

Page: Coagulation

Page: COVID-19 & Thrombosis Research

Page: COVID-19 and Clotting Blog Post PART 2

Page: Emerging Therapeutic Targets for Hereditary Angioedema

Page: Factor VIII (FVIII)

Page: Factor X (FX)

Page: Factor XI (FXI)

Page: Factor XII (FXII)

Page: Factor XIII

Page: Factor XIII (FXIII)

Page: Fibrinolysis

Page: Hemophilia

Page: Heparin

Page: Heparin in the News - The Genene Jones “Killer Nurse” Story

Page: HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

Page: HTRS 2019 Conference Summary

Page: Hypercoagulation During Sickle Cell Disease

Page: ISTH 2020

Page: ISTH 2021

Page: IVIG

Page: Kininogen

Page: Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome – Part 2

Page: Prekallikrein/Kallikrein

Page: Protein C

Page: Protein S

Page: Rossix

Page: Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

Page: The Chromogenic Factor X Assay (CFX)

Page: The Latest Research on Direct Oral Anticoagulant (DOAC) Interferences in Testing

Page: THE NEW NOVEL ANTICOAGULANTS XI(a) and XII(a). THE CONTACT FACTOR INHIBITORS: Battling thromboembolism.

Page: Thrombin Generation Assays

Page: Thrombophilia

Page: THSNA 2020 Virtual Meeting

Page: THSNA 2022 Recap

Page: Tools for Sickle Cell Disease Research

Page: UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?

Page: Videos

News: 2nd Annual Nonalcoholic Steatohepatitis (NASH) Summit

News: 59th American Society of Hematology (ASH 2017) Annual Meeting & Exposition

News: AACC 2021 Press Release

News: Are your patients getting the proper level of anticoagulation?

News: Assays Available from Diapharma

News: Assays for IVIG Testing

News: Cambridge Healthtech Institute (CHI) Discovery on Target - NASH & Fibrosis Conference

News: Celebrate 35 years of Technoclone and a Special Ceveron® s100 price

News: Celebrate with DiaPharma at THSNA 2022 and learn about Ceveron® s100

News: Clot Club #32

News: Clot Club #9

News: Clot Club: Hypercoagulation During Sickle Cell Disease

News: Comprehensive Solutions for Anticoagulation Research

News: Contact System Cross-Talk: Tools for Investigating Contact Activation Pathway

News: Count on Diapharma for COVID-19 Related Thrombosis Research Products

News: Diapharma expands line of proteins

News: DiaPharma is excited to bring you the latest at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo

News: Diapharma Newsletter Spring 2017

News: Explore Solutions from DiaPharma at AACC 2021

News: Factor XIII Assays to Fit Your Needs

News: Hemostasis Gordon Research Conference (GRC): Defining the Interactions Between Blood, Cells, and Vessels in Hemostasis and Disease

News: Highest Quality Assays for IVIG and Albumin Safety Testing

News: Immunoglobulin Testing Assays

News: Interact LIVE with our partner Technoclone during the ISTH 2020 Congress!

News: KININ 2018 - Thank you from Diapharma

News: Learn the Latest from DiaPharma at ISTH 2021

News: NASH-TAG (Therapeutic Agents for Non-Alcoholic Steatohepatitis and Liver Fibrosis) Conference 2019

News: NEW! PKA Standard for IVIG and Albumin Safety Testing

News: PKA Products for Reliable, Convenient IVIG and Albumin Safety Testing

News: PRECISELY BALANCED HEMOSTASIS

News: Quality Products for Anticoagulation Research

News: Reliable Assays for IVIG Testing

News: Reliable Assays for IVIG Testing

News: Sickle Cell Matters

News: Supporting the Clinical Hemostasis Lab

News: Thrombin Generation Assay for Cancer Associated Thrombosis Research

News: Time-tested and Proven Chromogenic Substrates

News: Time-tested, Well-published and Proven Chromogenic Substrates

News: Visit DiaPharma at ISTH and Register to Win!

News: Why isn't this being funded?! Product Grant Opportunity from DiaPharma

News: You name it, Ceveron® s100 can do it

News: You Name It, I'll Do It - complete solutions for your hemostasis needs

News: You Name It, I'll Do It - The Ceveron® s100

News: Your Resource for COVID-19 Related Thrombosis and Fibrinolysis Products

News: YOUR SOURCE FOR HEMOPHILIA CLINICAL AND RESEARCH SOLUTIONS

Faq: Define a katal.

Faq: Describe heparin's interaction with antithrombin. Why is the anti-FXa method a better way to measure heparin activity?

Faq: Even though there is documentation that the anti-FXa method is better, how could a researcher determine antithrombin in plasma based on a thrombin method?

Faq: Factor X or anti-Xa Assay. Which Do I Use?

Faq: How do the pharmacokinetics of LMW heparins differ from UF heparin, and what are the therapeutic ranges for each?

Faq: How does heparin interact with antithrombin? Why is the anti-FXa method a better way to measure heparin activity?

Faq: How is functional activity of protein S tested?

Faq: I am getting lower levels of antithrombin than expected. What could I be doing wrong?

Faq: I need an assay that complies with the USP monograph for the determination of heparin activity. What test kits are suitable?

Faq: If I want to determine FX in plasma, but do not want to buy a kit, what other options are there?

Faq: In the Chromogenix Coatest® Heparin package insert, the section Limitations of the procedure states that in some pathological states, plasma alone my hydrolyze S-2222™, and that to determine the interference one should substitute FXa with an equal volume of buffer...Why is this necessary?

Faq: Is it OK to use glass tubes for the Chromogenix Factor VIII assay?

Faq: Sometimes when I run the Chromogenix Coamatic® FVIII assay, I see an upward drift in my activity from the first to the last samples. Why is this?

Faq: The Chromogenix Factor Xa reagent says it is 71 nkat, but I need to know what that is in g/ml and mol/ml.

Faq: What aspects must a scientist consider when choosing the best chromogenic substrate?

Faq: What can I use for calibrators & controls for Factor X?

Faq: What is a chromogenic substrate?

Faq: What is enzyme specificity and substrate selectivity?

Faq: What is the difference between Chromogenix Coamatic® FVIII, Coatest® SP FVIII, and Coatest® SP FVIII?

Faq: What is the difference between Chromogenix Coamatic® Heparin, Coatest® Heparin and the discontinued Coatest® Low Molecular Weight Heparin / Heparin?

Faq: What is the function of antithrombin and what is its interaction with thrombin and heparin?

Faq: What is the measurement principle behind the FVIII chromogenic kits?

Faq: What is the therapeutic range for Factor X?

Faq: Why can't I just use a FX clotting assay?

Faq: Why did Chromogenix discontinue Coatest® Antithrombin and replace it with Coamatic® Antithrombin?

Faq: Why is thrombin added in the Chromogenix Coamatic® FVIII factor reagent?